MOESM3 of Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
收藏Figshare2019-11-28 更新2026-04-08 收录
下载链接：
https://springernature.figshare.com/articles/MOESM3_of_Histone_methyltransferases_EHMT1_and_EHMT2_GLP_G9A_maintain_PARP_inhibitor_resistance_in_high-grade_serous_ovarian_carcinoma/11294228/1
下载链接
链接失效反馈官方服务：
资源简介：
Additional file 3: Tumor Microarray Patient Characteristics (H3K9me2 staining and Kaplan-Meier analysis includes only 92 primary tumors prior to therapy).
补充文件3：肿瘤微阵列患者特征（针对组蛋白H3第9位赖氨酸二甲基化染色（H3K9me2 staining）与Kaplan-Meier分析的部分，仅纳入92例治疗前原发性肿瘤）
提供机构：
Hyunmin Kim
创建时间：
2019-11-28
